Magnetic resonance imaging in comatose adults resuscitated after out-of-hospital cardiac arrest: A posthoc study of the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest trial
Australian Critical Care · 2025
DOI: 10.1016/j.aucc.2024.09.015 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Australian Critical Care, 2025. Verfasst von Glenn M Eastwood und 16 weiteren Autor:innen. Beteiligte Einrichtung: Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Department of Intensive Care, Austin Hospital, He…. Hauptthemen laut MEDLINE: Out-of-Hospital Cardiac Arrest, Magnetic Resonance Imaging, Coma, Hypercapnia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Board, Health Research Council of New Zealand, State of Connecticut Department of Health Care Access.
Themen: Reanimation
Abstract (Originalsprache)
BACKGROUND: Neuroimaging with magnetic resonance imaging (MRI) may assist clinicians in evaluating brain injury and optimising care in comatose adults resuscitated after out-of-hospital cardiac arrest (OHCA). However, contemporary international data on its use are lacking. AIM: The primary aim was to compare the patient characteristics, early postresuscitation care, and neurological outcomes of patients according to MRI use. METHODS: We performed a posthoc analysis of the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial, a multinational randomised trial comparing targeted mild hypercapnia or normocapnia in comatose adults after OHCA. RESULTS: After exclusions, 1639 patients enrolled in the TAME trial were analysed. Of these, 149 (9%) had an MRI. Compared to non-MRI patients, MRI patients were younger (58.9 versus 61.7 years, p: 0.02), had a longer median time from OHCA to return of spontaneous circulation (30 versus 25 min, p < 0.0001), and had a higher average arterial lactate level (8.78 versus 6.74 mmol/L, p < 0.0001) on admission to hospital. MRI patients were more likely to receive additional advanced diagnostic assessments during intensive care unit admission (p < 0.0001). At 6 months, 23 of 140 patients (16.4%) in the MRI group had a favourable neurological outcome, compared with 659 of 1399 patients (47.1%) in the no-MRI group (p < 0.001). On multivariable modelling, country of enrolment was the dominating predictor in the likelihood of an MRI being performed. CONCLUSIONS: In the TAME trial, 9% of patients had an MRI during their intensive care unit admission. Among these patients, only 16% had a favourable neurological outcome at 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Department of Intensive Care, Austin Hospital, Heidelberg, Australia. Electronic address: glenn.eastwood@austin.org.au.
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; University College Dublin Clinical Research Centre at St Vincents University Hospital, Dublin, Ireland.
- Department of Clinical Sciences Lund, Section of Cardiology, Skåne University Hospital and Lund University, Sweden.
- Department of Clinical Sciences Lund, Anesthesiology and Intensive Care, Lund University, Sweden; Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden.
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Te Toka Tumai Auckland, Auckland, New Zealand;…
Förderung
- Health Research Board
- Health Research Council of New Zealand
- State of Connecticut Department of Health Care Access
- National Health and Medical Research Council
Zitieren
APA
Eastwood, G. M., Bailey, M., Nichol, A. D., Dankiewicz, J., Nielsen, N., Parke, R., Cronberg, T., Olasveengen, T., Grejs, A. M., Iten, M., Haenggi, M., McGuigan, P., Wagner, F., Moseby-Knappe, M., Lang, M., Bellomo, R., & TAME trial investigators (2025). Magnetic resonance imaging in comatose adults resuscitated after out-of-hospital cardiac arrest: A posthoc study of the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest trial. Australian Critical Care. https://doi.org/10.1016/j.aucc.2024.09.015
Vancouver
Eastwood GM, Bailey M, Nichol AD, Dankiewicz J, Nielsen N, Parke R, et al. Magnetic resonance imaging in comatose adults resuscitated after out-of-hospital cardiac arrest: A posthoc study of the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest trial. Australian Critical Care. 2025. doi:10.1016/j.aucc.2024.09.015
BibTeX
@article{Eastwood2025,
author = {Eastwood, Glenn M and Bailey, Michael and Nichol, Alistair D and Dankiewicz, Josef and Nielsen, Niklas and Parke, Rachael and Cronberg, Tobias and Olasveengen, Theresa and Grejs, Anders M and Iten, Manuela and Haenggi, Matthias and McGuigan, Peter and Wagner, Franca and Moseby-Knappe, Marion and Lang, Margareta and Bellomo, Rinaldo and TAME trial investigators, TAME trial investigators},
title = {Magnetic resonance imaging in comatose adults resuscitated after out-of-hospital cardiac arrest: A posthoc study of the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest trial},
journal = {Australian Critical Care},
year = {2025},
doi = {10.1016/j.aucc.2024.09.015}
}
EUVIMED